NH - ナチュラル・ヘルス・トレンズ (NantHealth Inc.) ナチュラル・ヘルス・トレンズ

 NHのチャート


 NHの企業情報

symbol NH
会社名 Natural Health Trends Corp. (ナチュラル・ヘルス・トレンズ)
分野(sector) Technology   ハイテク
産業(industry) EDP Services  
業種 先端医療機器_テクノロジ―   一般消費財(Consumer Products)
概要 事業概要 ナントヘルス(NantHealth Inc.)はヘルスケアクラウドベースの情報技術(IT)企業である。同社は医療現場で実践的な健康情報を提供するために、単一の統合された臨床プラットフォームを通じて科学技術を統合する。同社はゲノムプロテオーム分光測定(GPS)がん検診を提供する。それは患者の腫瘍組織中に存在するタンパク質を、腫瘍および正常サンプルの全ゲノムおよびトランスクリプトーム配列決定と組み合わせて測定する分子検査と意思決定支援ソリューションである。また、ナント・オペレーティング・システム(NantOS)およびNantOSアプリケーションを、医療提供者と支払人、自営業の雇用者およびバイオ医薬品会社に提供する。同社はGPS Cancer、NantOS、NantOSアプリケーションを含む統合ソリューションであるCLINICSを提供する。CLINICSソリューションには、システム・インフラストラクチャ、ナレッジ・プラットフォーム、プロバイダ・プラットフォーム、およびPayorプラットフォームが含まれる。   ナチュラル・ヘルス・トレンズは米国の自然医薬品・化粧品販売会社。栄養補給商品やスキンケア製品などを提携ネットワ―クを通じて直接販売及び電子商取引で提供。主な商品は、「プレミアムノニジュ―ス」、「トリオティ―ン」、「クラスタ―X2」、「トリフュ―ジョン・マックス」、「アル―ラ」、「スキンダルジェンス」、「タイム・リストア」など。   NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer in United States, the United Kingdom, Singapore, and Canada. Its solutions include empower treatment decisions; improve patient outcomes; validate treatment options; enable high-quality care; lower costs; ensure appropriate reimbursement; and streamline implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.
本社所在地 609 Deep Valley Drive Suite 395 Rolling Hills Estates CA 90274 USA
代表者氏名 Patrick Soon-Shiong Patrick Soon-Shiong
代表者役職名 Chairman of the Board Chief Executive Officer Founder
電話番号 +1 310-853-7513
設立年月日 32478
市場名 NASDAQ Small Cap
ipoyear 2016年
従業員数 149人
url www.naturalhealthtrendscorp.com
nasdaq_url https://www.nasdaq.com/symbol/nh
adr_tso
EBITDA EBITDA(百万ドル) -39.55300
終値(lastsale) 1.42
時価総額(marketcap) 155449733.06
時価総額 時価総額(百万ドル) 153.26030
売上高 売上高(百万ドル) 88.36800
企業価値(EV) 企業価値(EV)(百万ドル) 336.31330
当期純利益 当期純利益(百万ドル) -42.82700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NantHealth Inc revenues increased 4% to $44.3M. Net loss before extraordinary items decreased 49% to $43.8M. Revenues reflect Softwareas-a-service increase of 9% to $32.4M Sequencing and molecular analysis increase of 84% to $1.8M Home health care services increase of 17% to $3M. Lower net loss reflects Loss from related party equity method in decrease of 86% to $6.2M (expense).

 NHのテクニカル分析


 NHのニュース

   NantHealth Acquires OpenNMS | FinSMEs  2020/07/28 09:16:19 FinSMEs
NantHealth, Inc. (NASDAQ: NH), a Culver City, Calif.-based next-generation, evidence-based, personalized healthcare company, acquired The OpenNMS Group, a Morrisville, NC-based open-source network management company
   NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform  2020/07/27 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the acquisition of The OpenNMS Group, Inc. (www.opennms.com), the world’s premier open-source network management company, which will operate as a subsidiary of NantHealth. The transaction closed on July 22, 2020. “OpenNMS has set the standard for open-source network monitoring since 2000 with its enterprise-grade network management platform,” s
   NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance  2020/06/25 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biomedical research from preclinical to clinical studies. This research looked into the discordance between genomic sequencing and transcriptome analysis, and how this may reflect a mechanism of resistance to therapy in tumors that has previously been under-recogniz
   NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program  2020/06/18 20:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on developmental therapeutics for immunotherapy, molecularly targeted agents and tumor biology during the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program. The program, held virtually from May 29-31, 2020, gathered oncology physicians, biotechnology executives, researchers, patient advocat
   NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow  2020/06/16 15:24:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will exhibit at the online America’s Health Insurance Plans (AHIP) Institute & Expo 2020, taking place June 16-18. NantHealth unveiled new Eviti® product updates to better assist payers as well as NaviNet® user interface to enhance the provider end user experience. The conference draws health insurance providers and decision makers from
   NantHealth Acquires OpenNMS | FinSMEs  2020/07/28 09:16:19 FinSMEs
NantHealth, Inc. (NASDAQ: NH), a Culver City, Calif.-based next-generation, evidence-based, personalized healthcare company, acquired The OpenNMS Group, a Morrisville, NC-based open-source network management company
   NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform  2020/07/27 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the acquisition of The OpenNMS Group, Inc. (www.opennms.com), the world’s premier open-source network management company, which will operate as a subsidiary of NantHealth. The transaction closed on July 22, 2020. “OpenNMS has set the standard for open-source network monitoring since 2000 with its enterprise-grade network management platform,” s
   NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance  2020/06/25 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biomedical research from preclinical to clinical studies. This research looked into the discordance between genomic sequencing and transcriptome analysis, and how this may reflect a mechanism of resistance to therapy in tumors that has previously been under-recogniz
   NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program  2020/06/18 20:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on developmental therapeutics for immunotherapy, molecularly targeted agents and tumor biology during the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program. The program, held virtually from May 29-31, 2020, gathered oncology physicians, biotechnology executives, researchers, patient advocat
   NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow  2020/06/16 15:24:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will exhibit at the online America’s Health Insurance Plans (AHIP) Institute & Expo 2020, taking place June 16-18. NantHealth unveiled new Eviti® product updates to better assist payers as well as NaviNet® user interface to enhance the provider end user experience. The conference draws health insurance providers and decision makers from
   Gurugram-Jaipur Highway: Toll worth Rs 2,500 crore collected in less than 4 years  2020/03/17 11:09:50 The Financial Express
Four years ago, the Ministry of Road Transport and Highways started collecting toll from Gurugram-Jaipur Highway, which is commonly known as National Highway (NH) 8, at three places.
   NantHealth Announces Appointment of Deanna L. Wise to Its Board of Directors  2020/03/12 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Deanna L. Wise, Senior Vice President and Chief Information Officer for Banner Health, to NantHealth’s board of directors. Deanna brings more than 25 years of experience in the development and maintenance of leading clinical IT systems in the hospital and health care industry. Wise joined Banner Health in 2019 and has focused
   AM Best Affirms Credit Ratings of Lincoln National Corporation and Most Subsidiaries; Upgrades Credit Ratings of Lincoln Life Assurance Company of Boston  2020/03/03 21:11:00 Business Wire
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” of The Lincoln National Life Insurance Company and its wholly owned subsidiary, Lincoln Life & Annuity Company of New York (Syracuse, NY). Concurrently, AM Best has upgraded the FSR to A+ (Superior) from A (Excellent) and the Long-Term ICR to “aa-” from “a+” of Lincoln Life Assurance Company of Boston (LLAC) (Dover, NH). C
   NantHealth’s Cancer Therapy Pre-Authorization Platform Eviti Connect® Starts 2020 Strong with Two Expanded Programs  2020/02/27 13:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today two expanded programs with Eviti Connect®, NantHealth’s healthcare payer solution and provider decision support software. A leading U.S. Medicaid health plan expanded its coverage and one of the largest non-profit, rural health plans in the country offering coverage for 165,000 members will continue to drive high-value oncological care with Evi
   NantHealth : to Report 2019 Fourth-Quarter Financial Results and... | MarketScreener  2020/02/24 17:43:13 MarketScreener
Culver City, Calif. - February 24, 2020 - NantHealth, Inc. , a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its… | February 24, 2020

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ナチュラル・ヘルス・トレンズ NH NantHealth Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)